首页> 美国卫生研究院文献>Springer Open Choice >A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel Carboplatin 5-FU and Radiation Therapy in Patients with Stage II and III Esophageal Cancer

【2h】

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel Carboplatin 5-FU and Radiation Therapy in Patients with Stage II and III Esophageal Cancer

机译：II期和III期食管癌患者联合紫杉醇卡铂5-FU和放射疗法的高活性和耐受性新辅助方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe present phase II study aimed to assess the feasibility and efficacy of a new paclitaxel-based neoadjuvant chemoradiation regimen followed by surgery in patients with stage II–III esophageal cancer.

机译：背景本II期研究旨在评估新的基于紫杉醇的新辅助放化疗方案在II-III期食管癌患者中进行手术的可行性和有效性。

著录项

期刊名称 Springer Open Choice
作者
L. van de Schoot; E. A. P. M. Romme; M. J. van der Sangen; G. J. Creemers; G. van Lijnschoten; O. J. Repelaer van Driel; H. J. T. Rutten; G. A. P. Nieuwenhuijzen;
展开▼
作者单位

展开▼
年(卷),期 -1(15),1
年度 -1
页码 88–95
总页数 8
原文格式 PDF
正文语种
中图分类外科学;
关键词
Esophageal cancer Neoadjuvant chemoradiation Paclitaxel Pathologic complete response Tumor regression grade;

机译：食道癌;新辅助放化疗;紫杉醇;病理完全缓解;肿瘤消退等级;

相似文献

外文文献
中文文献
专利

1. A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer. [J] . van-de-Schoot L, Romme EA, van-der-Sangen MJ, Annals of surgical oncology . 2008,第1期

机译：II期和III期食管癌患者联合紫杉醇，卡铂，5-FU和放射疗法的高活性且可耐受的新辅助方案。
2. A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer [J] . L. van de Schoot MD, E. A. P. M. Romme MD, M. J. van der Sangen MD, Annals of Surgical Oncology . 2008,第1期

机译：II期和III期食管癌患者联合紫杉醇，卡铂，5-FU和放射治疗的高活性和耐受性新辅助方案
3. 747 POSTER Final efficacy results of a neoadjuvant chemoradiation phase II trial: paclitaxel, carboplatin and 5-FU with concomitant 45 Gy radiotherapy for stage II-III oesophageal cancer [J] . European Journal of Cancer Supplements . 2005,第2期

机译：747 POSTER新辅助化学放疗II期试验的最终疗效结果：紫杉醇，卡铂和5-FU联合45 Gy放疗治疗II-III期食管癌
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center (Ontario). [D] . Sinclair, Suzanne Marie. 2003

机译：金斯敦地区癌症中心（安大略省）对III期非小细胞肺癌患者进行化学放射治疗的有效性。
6. Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III HER2-positive breast cancer patients: a phase 2 open-label multicenter randomized trial [O] . Liang Huang, Sheng Chen, Wentao Yang, 2015

机译：曲妥珠单抗和紫杉醇方案联合卡铂或表柔比星作为新辅助疗法对临床II-III期HER2阳性乳腺癌患者的疗效和安全性分析：第2期开放标签多中心随机试验
7. A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer [O] . 2008

机译：II期和III期食管癌患者联合紫杉醇，卡铂，5-FU和放射治疗的高活性和耐受性新辅助方案

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel Carboplatin 5-FU and Radiation Therapy in Patients with Stage II and III Esophageal Cancer

摘要

著录项

相似文献

相关主题

期刊订阅